These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3472489)

  • 21. Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.
    Thadepalli H; Gollapudi SV; Chuah SK
    Antimicrob Agents Chemother; 1986 Oct; 30(4):574-6. PubMed ID: 3539011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.
    Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 1999 Jan; 43(1):77-84. PubMed ID: 9869569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.
    Hardy DJ; Swanson RN; Hensey DM; Ramer NR; Bower RR; Hanson CW; Chu DT; Fernandes PB
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1768-74. PubMed ID: 3435123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endocarditis and bacteremia caused by Enterobacter agglomerans].
    Muñoz Sanz A; García de la Llana F; Fernández Mora G; Blanco Palenciano J
    Med Clin (Barc); 1991 Mar; 96(11):436-7. PubMed ID: 2046434
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620 compared to that of other antimicrobial agents.
    Hirschhorn L; Neu HC
    Chemotherapy; 1987; 33(1):28-39. PubMed ID: 3549179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition kinetics and pharmacokinetics--pharmacodynamic integration of difloxacin against Staphylococcus aureus isolates from rabbits.
    Fernández-varón E; Cárceles CM; Marín P; Vancraeynest D; Montes A; Sotillo J; García-Martínez JD
    Res Vet Sci; 2008 Feb; 84(1):90-4. PubMed ID: 17573085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.
    Bayer AS; Li C; Ing M
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1837-41. PubMed ID: 9661030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae.
    Su J; Guo Q; Li Y; Wu S; Hu F; Xu S; Wang M
    J Antimicrob Chemother; 2018 Nov; 73(11):3176-3180. PubMed ID: 30099554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA; Tayeb OS
    Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of experimental Pseudomonas corneal ulcers with enoxacin, a quinolone antibiotic.
    Sugar A; Cohen MA; Bien PA; Griffin TJ; Heifetz CL; Mehta S
    Arch Ophthalmol; 1986 Aug; 104(8):1230-2. PubMed ID: 3461752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
    Verbist L
    J Antimicrob Chemother; 1987 Sep; 20(3):363-72. PubMed ID: 3119552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of cefoperazone in combination with sulbactam in experimental Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Fournier MA
    J Antimicrob Chemother; 1993 Sep; 32(3):453-8. PubMed ID: 8262867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activities of enoxacin and 17 other antimicrobial agents against multiply resistant, gram-negative bacteria.
    Rudrik JT; Cavalieri SJ; Britt EM
    Antimicrob Agents Chemother; 1984 Jul; 26(1):97-100. PubMed ID: 6591853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Spondylodiscitis caused by Enterobacter aerogenes].
    Strady C; Bossi P; Bricaire F
    Presse Med; 2000 Sep; 29(25):1406. PubMed ID: 11036515
    [No Abstract]   [Full Text] [Related]  

  • 36. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus.
    Kim YS; Liu Q; Chow LL; Chambers HF; Täuber MG
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3325-7. PubMed ID: 9835540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    Infection; 1986; 14 Suppl 3():S196-202. PubMed ID: 3463542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activities of A-56619 (difloxacin) and A-56620, two aryl fluoroquinolones.
    Digranes A; Dibb WL
    Chemotherapy; 1988; 34(4):298-307. PubMed ID: 3208547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
    Entenza JM; Que YA; Vouillamoz J; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.